Search company, investor...
Novonate company logo


Founded Year



Acquired | Acquired

About Novonate

Novonate is a medical device company. The company develops LifeBubble a device that focuses on umbilical catheter protection and securement to improve safety for neonates in the intensive care setting. It manufactures and delivers high-impact diagnostic and therapeutic products that help clinicians and hospitals preserve and restore patient dignity. Novonate was founded in 2017 and is based in South San Francisco, California. In February 2023, Novonate was acquired by Laborie Medical Technologies. The terms of the transaction were not disclosed.

Headquarters Location

395 Oyster Point Boulevard 501

South San Francisco, California, 94080,

United States

Missing: Novonate's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Novonate's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Novonate

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Novonate is included in 2 Expert Collections, including Medical Devices.


Medical Devices

8,633 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,901 items

Latest Novonate News

Pediatric Medical Devices Global Market Report 2023: Featuring TSE Medical, GE Healthcare, Hamilton Medical, Fritz Stephan, Novonate & More

Mar 15, 2023

The global pediatric medical devices market size is expected to reach USD 51.9 billion by 2030, expanding at a CAGR of 7.8% over the forecast period. The rising prevalence of chronic diseases among children such as asthma, cystic fibrosis, diabetes, epilepsy, and technological advancements in pediatric medical devices are the major growth-propelling factors for the market. Pediatric medical devices diagnose or treat diseases from birth through adolescence. The Federal Food, Drug, and Cosmetic Act consist of pediatric patients aged 21 or younger at the time of the treatment. In the U.S., the commercialization and development of pediatric medical devices lag significantly behind the medical devices for adults. In the last few years, only 24% of lifesaving medical devices have been approved by the FDA that can be used for childcare, and the majority of its users are 12 years and above. The COVID-19 pandemic has put the medical device industry at the center with unparalleled demand for personal protective equipment, diagnostic tests, ventilators, and other critical medical supplies. However, the pediatric medical device industry is highly impacted by the substantial decrease in the number of surgeries, many of which are being canceled or postponed so that hospitals and clinics can focus their resources on treating COVID-19 patients. The reopening of manufacturing units and supply-chain is expected to grow the market of pediatric medical devices. The development and design of pediatric medical devices continue to be an exciting field. There are only a few pediatric devices in the market which is forcing pediatric professionals to suggest alternative ways of treating children using devices mainly made for adults. Pediatric medical devices cover a wide range of indications and risks associated with child care. It also helps to reduce disease burden and improve the quality of life for many children. Various innovation competitions took place to support new and advanced pediatric medical devices. For instance, since 2013, the "Make Your Medical Device Pitch for Kids" international competition has focused on supporting and identifying innovations that will make a substantial improvement in pediatric care. Pediatric Medical Devices Market Highlights The anesthesia and respiratory care devices segment is expected to showcase the fastest CAGR over the forecast period as it is a commonly used product among children In Vitro Diagnostic (IVD) Devices segment held the largest share as of 2022 owing to the accurate and error-free diagnostic through the product The pediatric clinics segment is expected to showcase lucrative CAGR over the forecast period as these clinics are especially focused on children's care The hospitals held the largest share as of 2022 owing to the high number of patient admission in the hospitals Key Attributes:

Novonate Frequently Asked Questions (FAQ)

  • When was Novonate founded?

    Novonate was founded in 2017.

  • Where is Novonate's headquarters?

    Novonate's headquarters is located at 395 Oyster Point Boulevard, South San Francisco.

  • What is Novonate's latest funding round?

    Novonate's latest funding round is Acquired.

  • Who are the investors of Novonate?

    Investors of Novonate include Laborie Medical Technologies, National Capital Consortium for Pediatric Device Innovation, MedTech Innovator and Medical Technology Venture Partners.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.